Immunovant
Alexandria Zieba is an experienced professional with a robust background in regulatory submissions and medical writing, currently serving as Senior Director for Global Regulatory Submissions and Senior Director for Medical Writing & Regulatory Business Operations at Immunovant since April 2022. Prior roles at the organization include Director of Medical Writing and Regulatory Business Operations and Associate Director of Medical Writing Operations. Additionally, Alexandria has been the Business Owner of MNCS LLC since January 2005 and has experience working in a chemistry research laboratory at IUPUI from October 2018 to January 2020. Alexandria holds a Bachelor of Science in Chemistry from Indiana University Indianapolis.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.